当前位置:首页 - 行情中心 - 振德医疗(603301) - 财务分析 - 现金流量表

振德医疗

(603301)

  

流通市值:52.17亿  总市值:52.17亿
流通股本:2.66亿   总股本:2.66亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,147,808,916.174,291,067,036.923,234,303,404.672,030,560,511.35
收到的税费返还38,578,801.7169,498,665.05104,008,218.4352,828,134.52
收到其他与经营活动有关的现金10,307,314.9480,579,808.7244,283,401.565,954,138.99
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,196,695,032.814,541,145,510.693,382,595,024.62,149,342,784.86
购买商品、接受劳务支付的现金717,154,156.322,568,648,209.511,991,557,515.141,236,247,150.35
支付给职工以及为职工支付的现金265,239,585.2922,400,351.07691,701,336.53456,597,897.36
支付的各项税费134,087,464.68246,195,759.42270,114,945.68151,634,671.69
支付其他与经营活动有关的现金107,983,784.48342,758,204.01269,703,110.55191,027,727.26
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,224,464,990.684,080,002,524.013,223,076,907.92,035,507,446.66
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-27,769,957.87461,142,986.68159,518,116.7113,835,338.2
二、投资活动产生的现金流量:
收回投资收到的现金37,123,685.721,283,534,439.31450,000,000250,000,000
取得投资收益收到的现金--10,330,414.592,981,849.32
处置固定资产、无形资产和其他长期资产收回的现金净额-121,590,516.0350,310,069.39310,069.39
收到的其他与投资活动有关的现金-3,620,000--
投资活动现金流入的平衡项目0000
投资活动现金流入小计37,123,685.721,408,744,955.34510,640,483.98253,291,918.71
购建固定资产、无形资产和其他长期资产支付的现金199,348,317.46769,689,728.42495,686,681.03306,639,982.44
投资支付的现金12,040,258.41,358,382,431.2605,365,500355,365,500
取得子公司及其他营业单位支付的现金-48,660,00048,660,00048,660,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计211,388,575.862,176,732,159.621,149,712,181.03710,665,482.44
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-174,264,890.14-767,987,204.28-639,071,697.05-457,373,563.73
三、筹资活动产生的现金流量:
取得借款收到的现金740,000,0001,419,260,0001,419,260,0001,382,760,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计740,000,0001,419,260,0001,419,260,0001,382,760,000
偿还债务支付的现金200,000,0001,395,000,0001,011,000,000971,000,000
分配股利、利润或偿付利息支付的现金2,688,902.8159,395,258.04152,199,055.0615,100,931.33
其中:子公司支付给少数股东的股利、利润--1,339,241.3400,000
支付其他与筹资活动有关的现金1,684,523.4234,296,112.4521,658,602.8921,272,561.94
筹资活动现金流出平衡项目0000
筹资活动现金流出小计204,373,426.221,588,691,370.491,184,857,657.951,007,373,493.27
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额535,626,573.78-169,431,370.49234,402,342.05375,386,506.73
四、汇率变动对现金及现金等价物的影响-678,206.7421,204,896.87237,831.4913,250,391.75
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额332,913,519.03-455,070,691.22-244,913,406.8145,098,672.95
加:期初现金及现金等价物余额589,333,1151,044,403,806.221,044,403,806.221,044,403,806.22
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额922,246,634.03589,333,115799,490,399.411,089,502,479.17
补充资料:
净利润-397,210,867.43-167,287,596.33
资产减值准备-41,817,004.2-31,403,149.56
固定资产和投资性房地产折旧-221,223,838.5-122,920,492.41
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-221,223,838.5-122,920,492.41
无形资产摊销-25,299,364.67-12,628,698.04
长期待摊费用摊销-1,272,957.74-560,675.11
处置固定资产、无形资产和其他长期资产的损失--93,432,002.11--87,995.24
固定资产报废损失-3,920,794.91-718,467.4
公允价值变动损失-12,245,552.1-926,628.78
财务费用-4,429,571.28-3,623,776.06
投资损失--11,073,234.7--1,274,897.18
递延所得税-13,386,532.87-7,771,634.05
其中:递延所得税资产减少-14,250,144.31-9,812,534.59
递延所得税负债增加--863,611.44--2,040,900.54
存货的减少--10,441,578.99--2,322,399.7
经营性应收项目的减少--255,367,799.86--256,365,386.24
经营性应付项目的增加-100,419,671.01-23,227,892.67
现金的期末余额-589,333,115-1,089,502,479.17
减:现金的期初余额-1,044,403,806.22-1,044,403,806.22
公告日期2025-04-262025-04-262024-10-302024-08-30
审计意见(境内)标准无保留意见
TOP↑